Join
Live feed
·
PRReleasevia Quantisnow
Aimmune Therapeutics, Inc. logo

Nestlé commences tender offer for Aimmune Therapeutics, Inc.

ByQuantisnow·Wall Street's wire, on your screen.
Full content unavailable. See the original source below.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AIMT (Aimmune Therapeutics, Inc.) and more on Quantisnow.